---
figid: PMC2637898__1756-8722-2-2-3
figlink: /pmc/articles/PMC2637898/figure/F3/
number: Figure 3
caption: 'EGFR signal transduction pathways. Three steps can be schematically defined
  in the activation of EGFR-dependent intracellular signaling. First, the binding
  of a receptor-specific ligand occurs in the extracellular portion of the EGFR or
  of one of the EGFR-related receptors (HER2, HER3, or HER4). Second, the formation
  of a functionally active EGFR-EGFR dimer (homodimer) or an EGFR-HER2, EGFR-HER3,
  or EGFR-HER4 dimer (heterodimer) causes the ATP-dependent phosphorylation of specific
  tyrosine residues in the EGFR intracellular domain. Third, this phosphorylation
  triggers a complex program of intracellular signals to the cytoplasm and then to
  the nucleus. The two major intracellular pathways activated by EGFR are the RAS-RAF-MEK-MAPK
  pathway, which controls gene transcription, cell-cycle progression from the G1 phase
  to the S phase, and cell proliferation, and the PI3K-Akt pathway, which activates
  a cascade of anti-apoptotic and prosurvival signals. bFGF, basic fibroblast growth
  factor, HB-EGF, heparin-binding EGF, MAPK, mitogen-activated protein kinase, PI3K,
  phosphatidylinositol 3,4,5-kinase, TGFa transforming growth factor alpha, and VEGF,
  vascular endothelial growth factor. Used with permission from: NEJM 2008 Ciardiello
  et al.).'
pmcid: PMC2637898
papertitle: Recent advances of novel targeted therapy in non-small cell lung cancer.
reftext: Jed A Katzel, et al. J Hematol Oncol. 2009;2:2-2.
pmc_ranked_result_index: '83181'
pathway_score: 0.9495637
filename: 1756-8722-2-2-3.jpg
figtitle: EGFR signal transduction pathways
year: '2009'
organisms: Homo sapiens
ndex: c67a0df7-deeb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2637898__1756-8722-2-2-3.html
  '@type': Dataset
  description: 'EGFR signal transduction pathways. Three steps can be schematically
    defined in the activation of EGFR-dependent intracellular signaling. First, the
    binding of a receptor-specific ligand occurs in the extracellular portion of the
    EGFR or of one of the EGFR-related receptors (HER2, HER3, or HER4). Second, the
    formation of a functionally active EGFR-EGFR dimer (homodimer) or an EGFR-HER2,
    EGFR-HER3, or EGFR-HER4 dimer (heterodimer) causes the ATP-dependent phosphorylation
    of specific tyrosine residues in the EGFR intracellular domain. Third, this phosphorylation
    triggers a complex program of intracellular signals to the cytoplasm and then
    to the nucleus. The two major intracellular pathways activated by EGFR are the
    RAS-RAF-MEK-MAPK pathway, which controls gene transcription, cell-cycle progression
    from the G1 phase to the S phase, and cell proliferation, and the PI3K-Akt pathway,
    which activates a cascade of anti-apoptotic and prosurvival signals. bFGF, basic
    fibroblast growth factor, HB-EGF, heparin-binding EGF, MAPK, mitogen-activated
    protein kinase, PI3K, phosphatidylinositol 3,4,5-kinase, TGFa transforming growth
    factor alpha, and VEGF, vascular endothelial growth factor. Used with permission
    from: NEJM 2008 Ciardiello et al.).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - SOS1
  - ERBB3
  - EGFR
  - MAPK11
  - MAPK9
  - NRAS
  - HRAS
  - MAPK13
  - MAPK14
  - EGF
  - VEGFC
  - MAPK8
  - PIK3CB
  - HBEGF
  - AKT2
  - KRAS
  - RAF1
  - PIK3CD
  - MAPK10
  - VEGFB
  - AKT3
  - MAP2K1
  - MAPK1
  - AKT1
  - MAP2K2
  - PIK3R6
  - PIK3R5
  - PIK3CG
  - PIK3CA
  - BRAF
  - ARAF
  - SOS2
  - ERBB4
  - VEGFA
  - MAPK12
  - MAPK3
  - PGF
  - PIK3R3
  - PIK3R4
  - VEGFD
  - TGFA
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: EGFR,HER2,
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: HER3,orHER4
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: EGFR,HER2,
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: HB-EGF
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: HER4
  symbol: HER4
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: TGfa
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
